Ropeginterferon alfa-2b

ropeginterferon alfa-2b · AOP Orphan Pharmaceuticals AG

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Ropeginterferon alfa-2b, covering 2022-10-06 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis) [Phase 1]

See pricing